Literature DB >> 16988257

Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.

Sonja Lütjen1, Sabine Soltek, Simona Virna, Martina Deckert, Dirk Schlüter.   

Abstract

Toxoplasma gondii induces a persistent central nervous system infection, which may be lethally reactivated in AIDS patients with low CD4 T-cell numbers. To analyze the role of CD4 T cells for the regulation of parasite-specific CD8 T cells, mice were infected with transgenic T. gondii expressing the CD8 T-cell antigen beta-galactosidase (beta-Gal). Depletion of CD4 T cells prior to infection did not affect frequencies of beta-Gal(876-884)-specific (consisting of residues 876 to 884 of beta-Gal) CD8 T cells but resulted in a pronounced reduction of intracerebral beta-Gal-specific gamma interferon (IFN-gamma)-producing and cytolytic CD8 T cells. After cessation of anti-CD4 treatment a normal T. gondii-specific CD4 T-cell response developed, but IFN-gamma production of intracerebral beta-Gal-specific CD8 T cells remained impaired. The important supportive role of CD4 T cells for the optimal functional activity of intracerebral CD8 T cells was also observed in mice that had been depleted of CD4 T cells during chronic toxoplasmosis. Reinfection of chronically infected mice that had been depleted of CD4 T cells during either the acute or chronic stage of infection resulted in an enhanced proliferation of beta-Gal-specific IFN-gamma-producing splenic CD8 T cells. However, reinfection of chronically infected mice that had been depleted of CD4 T cells in the acute stage of infection did not reverse the impaired IFN-gamma production of intracerebral CD8 T cells. Collectively, these findings illustrate that CD4 T cells are not required for the induction and maintenance of parasite-specific CD8 T cells but, depending on the stage of infection, the infected organ and parasite challenge infection regulate the functional activity of intracerebral CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988257      PMCID: PMC1594890          DOI: 10.1128/IAI.00098-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis.

Authors:  D M Israelski; F G Araujo; F K Conley; Y Suzuki; S Sharma; J S Remington
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

Review 3.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

Authors:  R Gazzinelli; Y Xu; S Hieny; A Cheever; A Sher
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

6.  Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.

Authors:  F G Araujo
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

7.  Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.

Authors:  C R Brown; C A Hunter; R G Estes; E Beckmann; J Forman; C David; J S Remington; R McLeod
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

8.  Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response.

Authors:  M Deckert-Schlüter; D Schlüter; D Schmidt; G Schwendemann; O D Wiestler; H Hof
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 9.  Modulation of the immune response by transforming growth factor beta.

Authors:  A Fontana; D B Constam; K Frei; U Malipiero; H W Pfister
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

10.  Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products.

Authors:  D Schlüter; J Löhler; M Deckert; H Hof; G Schwendemann
Journal:  J Neuroimmunol       Date:  1991-03       Impact factor: 3.478

View more
  18 in total

1.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

3.  Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.

Authors:  Gopala Nishanth; Monika Sakowicz-Burkiewicz; Ulrike Händel; Stefanie Kliche; Xiaoqian Wang; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

4.  Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.

Authors:  Nicolas Blanchard; Federico Gonzalez; Marie Schaeffer; Nathalie T Joncker; Tiffany Cheng; Anjali J Shastri; Ellen A Robey; Nilabh Shastri
Journal:  Nat Immunol       Date:  2008-06-29       Impact factor: 25.606

5.  Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Emma H Wilson; Elia D Tait; Barbara A Fox; David S Roos; David J Bzik; Florence Dzierszinski; Christopher A Hunter
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

6.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

7.  Diverse roles for T-bet in the effector responses required for resistance to infection.

Authors:  Gretchen Harms Pritchard; Aisling O'Hara Hall; David A Christian; Sagie Wagage; Qun Fang; Gaia Muallem; Beena John; Arielle Glatman Zaretsky; William G Dunn; Jacqueline Perrigoue; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2015-01-02       Impact factor: 5.422

8.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

9.  IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen.

Authors:  Qila Sa; Jerold Woodward; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

Review 10.  A latent ability to persist: differentiation in Toxoplasma gondii.

Authors:  Victoria Jeffers; Zoi Tampaki; Kami Kim; William J Sullivan
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.